User profiles for "author:Jeong Eun Min"

Jeong Eun Min

Centre for Health Evaluation and Outcome Sciences
Verified email at cheos.ubc.ca
Cited by 1782

Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study

LA Pearce, JE Min, M Piske, H Zhou, F Homayra… - Bmj, 2020 - bmj.com
Objective To compare the risk of mortality among people with opioid use disorder on and off
opioid agonist treatment (OAT) in a setting with a high prevalence of illicitly manufactured …

Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users

L Wang, JE Min, E Krebs, E Evans, D Huang… - International Journal of …, 2017 - Elsevier
Background Polydrug use may challenge effective treatment for substance use disorders.
We evaluate whether secondary substance use modifies the association between treatment …

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure

LC Swenson, JE Min, CK Woods, E Cai, JZ Li… - Aids, 2014 - journals.lww.com
Background: The clinical implications of emergent HIV drug resistance on samples with low-
level viraemia (LLV< 1000 copies/ml) remain unclear. We undertook the present analysis to …

Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort …

A Slaunwhite, JE Min, H Palis, K Urbanoski, B Pauly… - bmj, 2024 - bmj.com
Objective To determine the effect of opioid and stimulant Risk Mitigation Guidance (RMG)
dispensations on mortality and acute care visits during the dual public health emergencies …

[HTML][HTML] Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000–2010)

A Carter, J Eun Min, W Chau, VD Lima, M Kestler… - PloS one, 2014 - journals.plos.org
Objectives We measured gender differences in “Quality of Care”(QOC) during the first year
after initiation of antiretroviral therapy and investigated factors associated with poorer QOC …

Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada

M Kurz, JE Min, LM Dale, B Nosyk - Journal of substance abuse treatment, 2022 - Elsevier
Background Pharmacological treatments for opioid use disorder are essential, life-saving
medications, yet successful induction of them and long-term retention on them is limited in …

Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting

L Wang, D Panagiotoglou, JE Min, K DeBeck… - Drug and alcohol …, 2016 - Elsevier
Background People who inject drugs (PWID) face barriers to healthcare due to reasons
including comorbidity. We evaluated access to health and social services by three of the …

Characterizing retention in HAART as a recurrent event process: insights into 'cascade churn'

B Nosyk, L Lourenço, JE Min, D Shopin, VD Lima… - Aids, 2015 - journals.lww.com
Objective: The benefits of HAART rely on continuous lifelong treatment retention. We used
linked population-level health administrative data to characterize durations of HAART …

Ending the epidemic in America will not happen if the status quo continues: modeled projections for human immunodeficiency virus incidence in 6 US cities

B Nosyk, X Zang, E Krebs, JE Min… - Clinical Infectious …, 2019 - academic.oup.com
Abstract We estimated 10-year (2020–2030) trajectories for human immunodeficiency virus
incidence in 6 US cities. Estimated incidence will only decrease in 2 of 6 cities, with the …

Opioid agonist therapy and mortality among First Nations and other residents with concurrent alcohol use disorder in British Columbia, Canada: A population-based …

B Barker, JE Min, F Homayra, M Piske, S Sabeti… - Drug and alcohol …, 2023 - Elsevier
Background Despite the prevalence of alcohol use among people with opioid use disorder
(PWOUD) engaged in opioid agonist therapy (OAT), clinical care guidance for concurrent …